Breast Cancer Tissue Array of 96 Tissue Samples
      Home >> Welcome to Pantomics                                                                          Price List Download

Dedicated facility

 Catalog# BRC962 - Human breast cancer tissue array

   
Lot# Cores Size Cut Format QA/QC Price
1Slide
Price
Pack5
BRC96201 96 1.5mm 4um 8X12 H&E, IHC anti-Vimentin/Cytokeratin $150 $600
Order: sales@pantomics.com or call  1-415-863-2380, Form: Word or PDF; PDF data
 
   
Recommended applications: For Research use only. RNA or protein breast cancer/non-tumor tissue profiling using IHC or ISH; Antibody characterization.

Description:
Breast cancer tissue array, 96 cores, non-overlapping with BRC961, including 36 cases (purple/blue) of breast cancers and 12 cases of normal, reactive and  benign tumor tissues of the breast (pink) in duplicates. All the tissues were from surgical resection. They were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or APES coated Superfrost slides. They all have a guaranteed six months' shelf-life at 4C from the date of shipment. Each slide has >95% tissue core retention.
   
     

Array
position

Age

Sex

Histology

Grade

Stage (TNM)

AR

ER

PR

HER2

A1,B1

50

F

Normal

 

 

+, 1%

++, 2%

+++, 2%

-

A2,B2

47

F

Normal/hyperplasia

 

 

+, 5%

+, 1%

+++, 2%

-

A3,B3

40

F

Normal/hyperplasia

 

 

-

-

++, 2%

-

A4,B4

32

F

Normal/hyperplasia

 

 

++, 5%

++,1%

-

-

A5,B5

50

F

Granuloma

 

 

-

-

-

-

A6,B6

30

F

Granuloma

 

 

-

-

-

-

A7,B7

50

F

Fibrocystic changes

 

 

++, 5%

++, 1%

-

+

A8,B8

43

F

Fibrocystic changes

 

 

+, 2%

+, 5%

-

-

A9,B9

25

F

Fibroadenoma

 

 

++~+++, 30%

+++, 30%

+++, 15%

+~+++

A10,B10

20

F

Fibroadenoma

 

 

++, 20%

++~+++, 30%

+++, 50%

+

A11,B11

21

F

Fibroadenoma

 

 

++, 50%

+++, 80%

+++, 60%

+

A12,B12

50

F

Fibroadenoma

 

 

+, 10%

++, 15%

+++, 30%

+

C1,D1

43

F

Intra-ductal carcinoma

I

TisN0M0

-

-

-

+++

C2,D2

60

F

Intra-ductal carcinoma

I

TisN0M0

-

-

-

+++

C3,D3

37

F

Intra-ductal carcinoma

I

TisN0M0

++, 10%

++~+++, 80%

++~+++, 50%

+~++

C4,D4

41

F

Lobular carcinoma in situ

I

TisN0M0

-

+, 20%

+++, 80%

+

C5,D5

30

F

Phyllodes sarcoma

 

 

-

-

-

-

C6,D6

48

F

Invasive ductal carcinoma

II

T1N0M0

++, 50%

++~+++, 60%

+++, 80%

-

C7,D7

44

F

Invasive ductal carcinoma

II~III

T1N0M0

-

-

-

+++

C8,D8

61

F

Invasive ductal carcinoma

II~III

T1N0M0

+~++, 30%

+++, 100%

++, 50%

+

C9,D9

40

F

Invasive ductal carcinoma

II~III

T1N0M0

+~++, 30%

++, 60%

++~+++, 80%

++

C10,D10

38

F

Invasive ductal carcinoma

I~II

T1N0M0

+, 15%

+, 15%

++, 30%

++~+++

C11,D11

43

F

Invasive ductal carcinoma

III

T2N0M0

-

+, 20%

++, 30%

-

C12,D12

48

F

Invasive ductal carcinoma

II

T2N0M0

-

+~++, 50%

++~+++, 80%

-

E1,F1

62

F

Invasive ductal carcinoma

II~III

T2N0M0

-

+++, 90%

+++, 60%

+

E2,F2

47

F

Invasive ductal carcinoma

II~III

T2N2M0

-

++, 50%

++, 30%

+

E3,F3

59

F

Invasive ductal carcinoma

III

T2N0M0

-

-

-

-

E4,F4

72

F

Invasive ductal carcinoma

I~II

T2N1M0

-

-

-

-

E5,F5

36

F

Invasive lobular carcinoma

III

T2N2M0

-

-

-

+++

E6,F6

48

F

Invasive ductal carcinoma

II~III

T2N0M0

-

-

-

+++

E7,F7

44

F

Invasive ductal carcinoma

II~III

T2N0M0

-

+~++, 50%

-

-

E8,F8

56

F

Invasive ductal carcinoma

I~II

T2N0M0

++, 5%

-

-

+++

E9,F9

50

F

Invasive ductal carcinoma

II

T2N1M0

-

-

-

++~+++

E10,F10

50

F

Invasive ductal carcinoma

II~III

T2N0M0

++, 5%

+++, 80%

+++, 80%

+

E11,F11

83

F

Mucinous carcinoma

 

T4N0M0

+~++, 10%

+++, 80%

++, 50%

+

E12,F12

64

F

Invasive lobular carcinoma

III

T2N0M0

-

++~+++, 80%

++, 20%

-

G1,H1

58

F

Invasive ductal carcinoma

II

T2N1M0

-

-

-

-

G2,H2

32

F

Invasive ductal carcinoma

II~III

T3N1M0

-

-

++, 20%

++~+++

G3,H3

60

F

Invasive ductal carcinoma

II~III

T4N0M0

-

-

-

+++

G4,H4

58

F

Invasive ductal carcinoma

III

T1N0M0

-

-

-

-

G5,H5

54

F

Invasive ductal carcinoma

II~III

T3N3M0

-

-

-

++~+++

G6,H6

33

F

Invasive lobular carcinoma

III

T4N0M0

++, 20%

+++, 80%

+++, 50%

-

G7,H7

51

F

Invasive lobular carcinoma

II~III

T4N0M0

++, 30%

+++, 80%

-

-

G8,H8

55

F

Invasive ductal carcinoma

III

T3N1M0

-

+++, 80%

+++, 50%

-

G9,H9

36

F

Invasive ductal carcinoma

II~III

T3N1M0

++, 30%

++, 60%

++~+++, 60%

+++

G10,H10

42

F

Invasive ductal carcinoma

II~III

T3N0M0

+, 2%

+~++, 50%

-

+~++

G11,H11

36

F

Invasive ductal carcinoma

II

T4N0M0

++, 5%

+++, 90%

+++, 100%

+

G12,H12

36

F

Squamous cell carcinoma?

I~II

T3N1M0

-

-

-

+++

 
 

-------------------------------------------------------------------------------------------------
All Products | Ordering Information | Privacy Policy
Copyright © 2004-2005, Pantomics, Inc.
457 Mariposa Street, San Francisco, CA 94107, USA. Tel: 415-863-2380